An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.
Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span ...
Plus: How AI propelled Nvidia up the list and other insights from this year's survey of corporate reputations.
We recently compiled a list of the Jim Cramer Discussed These 10 Stocks, AI Power Demand & Healthcare. In this article, we ...
As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...
Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a ...
Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn ...
A Super Bowl ad for weight loss medications from telehealth company Hims & Hers is optimized to engage and infuriate ...
Experts fear a resurgence of infections in low-income countries if the ban were to continue. The waiver remains in place, ...
The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...